News and Analysis on Global Defense Defense, Technology, Warfare

FDA issues drug-eluting stent guidelines


Published: March 26, 2008 at 12:35 PM
WASHINGTON, March 26 (UPI) -- The U.S. Food and Drug Administration has issued draft guidelines to aid the development, testing and manufacture of coronary drug-eluting stents.

Such stents are used to open blocked heart arteries but concerns have arisen over clot formation in some patients several years after implantation.

The guidelines outline the agency's recommendations for premarket clinical evaluation and post-market studies, which the FDA said might provide data to better address potential safety concerns.

Each year in the United States, approximately 1 million patients undergo procedures to treat coronary atherosclerosis, also known as hardening or blockages of the heart arteries -- a condition that can cause angina and heart attacks, the FDA said. Some 650,000 of such patients are treated with drug-eluting stents that are coated with a medication that prevents the growth of scar tissue.

The draft guidance is available at http://www.fda.gov/cdrh/ode/guidance/6255.html.



© 2008 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.
» Next in Science: Canadian pine beetles out of food

CYCLONE MYANMUR
In this image from NASA's Atmospheric Infrared Sounder instrument on NASA's Aqua spacecraft, Cyclone Nargis is pictured when it was a Category one hurricane located 370 miles west of Yangon, Myanmar on May 1, 2008. Tropical Cyclone Nargis flooded the region on May 4, 2008. The death toll from the cyclone and its aftermath is feared to hit or exceed 100,000 lives. (UPI Photo/NASA/MODIS Rapid Response Team)
NASA satellite images show Tropical Cyclone Nargis in Myanmar
Full Photo | Slideshow